Matthew Ronsheim is of Innoviva, Inc.. Currently has a direct ownership of 40,510 shares of INVA, which is worth approximately $720,672. The most recent transaction as insider was on May 20, 2024, when has been sold 268 shares (Common Stock) at a price of $16.13 per share, resulting in proceeds of $4,322. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.5K
0% 3M change
n/a 12M change
Total Value Held $720,672

Matthew Ronsheim Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2024
SELL
Payment of exercise price or tax liability
$4,322 $16.13 p/Share
268 Reduced 0.66%
40,510 Common Stock
Mar 05 2024
BUY
Grant, award, or other acquisition
$189,987 $14.88 p/Share
12,768 Added 23.84%
40,778 Common Stock
Feb 20 2024
SELL
Payment of exercise price or tax liability
$12,750 $15.8 p/Share
807 Reduced 2.8%
28,010 Common Stock
Jan 18 2024
SELL
Payment of exercise price or tax liability
$25,680 $16.05 p/Share
1,600 Reduced 5.26%
28,817 Common Stock

Also insider at

ETTX
Entasis Therapeutics Holdings Inc. Healthcare
MR

Matthew Ronsheim

Waltham, MA

Track Institutional and Insider Activities on INVA

Follow Innoviva, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INVA shares.

Notify only if

Insider Trading

Get notified when an Innoviva, Inc. insider buys or sells INVA shares.

Notify only if

News

Receive news related to Innoviva, Inc.

Track Activities on INVA